Vestal Point Capital, LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Definium Therapeutics Inc | $8.53M | 0.3% |
| Denali Therapeutics Inc. | $7.68M | 0.3% |
| MYRIAD GENETICS INC | $7.52M | 0.3% |
| Tectonic Therapeutic, Inc.TECX | $6.84M | 0.3% |
| NovoCure Ltd | $6.79M | 0.2% |
| MAPLIGHT THERAPEUTICS INCMPLT | $6.76M | 0.2% |
| GILEAD SCIENCES, INC. | $6.14M | 0.2% |
| Voyager Therapeutics, Inc. | $5.80M | 0.2% |
| DBV TECHNOLOGIES S.A.DBVT | $5.75M | 0.2% |
| Mirum Pharmaceuticals, Inc. | $5.21M | 0.2% |
| NYXOAH SA | $5.09M | 0.2% |
| Nuvalent, Inc. | $4.63M | 0.2% |
| LENZ Therapeutics, Inc. | $4.40M | 0.2% |
| Rezolute, Inc. | $3.98M | 0.1% |
| Passage BIO, Inc.PASG | $3.60M | 0.1% |
| Sutro Biopharma, Inc. | $2.81M | 0.1% |
| Structure Therapeutics Inc.GPCR | $2.43M | 0.1% |
| Dyne Therapeutics, Inc. | $2.35M | 0.1% |
| Black Diamond Therapeutics, Inc.BDTX | $2.11M | 0.1% |
| OnKure Therapeutics, Inc. | $1.84M | 0.1% |
| FATE THERAPEUTICS INC | $1.69M | 0.1% |
| Alector, Inc. | $1.18M | 0.0% |
| Tenax Therapeutics, Inc. | $651.4K | 0.0% |
| REGENXBIO Inc. | $489.6K | 0.0% |
| MacroGenics, Inc. | $450.8K | 0.0% |